These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1994996)

  • 1. [A mild variant case of maple syrup urine disease].
    Ishikawa A; Okayasu T; Miyasaka K; Fukushima N; Takase A; Wagatsuma Y
    No To Hattatsu; 1991 Jan; 23(1):71-4. PubMed ID: 1994996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Maple syrup urine disease].
    Incesu L; Tasdemir HA; Yazicioglu AK; Belet U; Danaci M
    Radiol Med; 2001 Sep; 102(3):194-6. PubMed ID: 11677467
    [No Abstract]   [Full Text] [Related]  

  • 3. Maple syrup urine disease metabolites studies in cerebellum cultures.
    Silberberg DH
    J Neurochem; 1969 Jul; 16(7):1141-6. PubMed ID: 5816072
    [No Abstract]   [Full Text] [Related]  

  • 4. [Disorders of leucine, isoleucine and valine metabolism (maple syrup urine disease)].
    Vulović D; Vilhar N; Hajduković R; Marjanović B; Stojanović Lj
    Srp Arh Celok Lek; 1975 May; 103(5):419-36. PubMed ID: 1188483
    [No Abstract]   [Full Text] [Related]  

  • 5. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
    Kindt E; Halvorsen S
    Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Neonatal diagnosis of maple syrup urine disease and the influence of exchange blood transfusion.
    Russell A; Statter M; Shina A; Perlman M
    Isr J Med Sci; 1975 Nov; 11(11):1218-9. PubMed ID: 1205813
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme activity in classical and variant forms of maple syrup urine disease.
    Dancis J; Hutzler J; Snyderman SE; Cox RP
    J Pediatr; 1972 Aug; 81(2):312-20. PubMed ID: 5042489
    [No Abstract]   [Full Text] [Related]  

  • 8. Intermittent neurological symptoms in a girl with a maple syrup urine disease (MSUD) variant.
    Holmgren G; Brundin A; Gustavson KH; Sjögren S; Kleijer WJ; Niermeijer MF
    Neuropediatrics; 1980 Nov; 11(4):377-83. PubMed ID: 7207707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M aple syrup urine disease. A review with a report of an additional case.
    Schwartz JF; Kolendrianos ET
    Dev Med Child Neurol; 1969 Aug; 11(4):460-70. PubMed ID: 5805351
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intermittent maple syrup urine disease in a 12-year-old boy: clinical aspects, diagnosis and treatment].
    Fritsch G; Langenbeck U; Wendel U; Lehnert W; Palm W; Steger W
    Klin Padiatr; 1983; 195(5):351-4. PubMed ID: 6632715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute encephalopathy due to late-onset maple syrup urine disease in a school boy].
    Qu SQ; Yang LC; Luan Z; Du K; Yang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):161-4. PubMed ID: 22433398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body L-leucine oxidation in patients with variant form of maple syrup urine disease.
    Schadewaldt P; Bodner-Leidecker A; Hammen HW; Wendel U
    Pediatr Res; 2001 May; 49(5):627-35. PubMed ID: 11328944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
    Bindu PS; Shehanaz KE; Christopher R; Pal PK; Ravishankar S
    J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on "branched chain oxoacid aciduria" (maple syrup diseases)].
    Goedde HW; Blume KG; Möhlenbeck F; Rotthauwe HW; Simon HA; Lang K
    Med Klin; 1966 Dec; 61(52):2063-7. PubMed ID: 4385693
    [No Abstract]   [Full Text] [Related]  

  • 15. Variant maple syrup urine disease in mother and daughter.
    Zaleski LA; Dancis J; Cox RP; Hutzler J; Zaleski WA; Hill A
    Can Med Assoc J; 1973 Aug; 109(4):299-300 passim. PubMed ID: 4730202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is demyelination a feature of maple syrup urine disease?
    Müller K; Kahn T; Wendel U
    Pediatr Neurol; 1993; 9(5):375-82. PubMed ID: 8292212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the catabolism of branched-chain L-amino acids in cultured human skin fibroblasts.
    Schadewaldt P; Wendel U
    Pediatr Res; 1987 Nov; 22(5):591-4. PubMed ID: 3684388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT and MRI in maple syrup urine disease.
    Uziel G; Savoiardo M; Nardocci N
    Neurology; 1988 Mar; 38(3):486-8. PubMed ID: 3347354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical-genetic studies in maple syrup disease].
    Goedde HW; Blume KG
    Med Welt; 1968 Dec; 49():2699-703. PubMed ID: 5730703
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ophthalmological and histopathological findings in maple syrup disease].
    Franke G; Teuscher M; Knapp A; Seidlitz G
    Fortschr Ophthalmol; 1983; 80(6):457-9. PubMed ID: 6662450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.